Free Trial

Tempus AI, Inc.'s Lock-Up Period Set To End on December 11th (NASDAQ:TEM)

Tempus AI logo with Medical background

Tempus AI's (NASDAQ:TEM - Get Free Report) lock-up period is set to end on Wednesday, December 11th. Tempus AI had issued 11,100,000 shares in its initial public offering on June 14th. The total size of the offering was $410,700,000 based on an initial share price of $37.00. After the expiration of Tempus AI's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Analyst Ratings Changes

A number of research firms have recently issued reports on TEM. Loop Capital lifted their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a research note on Tuesday, October 15th. Piper Sandler restated a "neutral" rating and issued a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Bank of America cut shares of Tempus AI from a "buy" rating to a "neutral" rating and boosted their price objective for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Needham & Company LLC restated a "buy" rating and issued a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $54.22.

Get Our Latest Analysis on Tempus AI

Tempus AI Stock Up 3.0 %

Tempus AI stock traded up $1.70 during trading hours on Wednesday, hitting $57.99. The company had a trading volume of 1,493,666 shares, compared to its average volume of 1,199,152. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a one year low of $22.89 and a one year high of $79.49. The business's 50-day moving average is $53.41.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. NEA Management Company LLC acquired a new stake in shares of Tempus AI during the 2nd quarter worth approximately $160,048,000. Novo Holdings A S acquired a new stake in shares of Tempus AI during the 2nd quarter worth approximately $142,605,000. Revolution Growth Management Company Inc. acquired a new stake in shares of Tempus AI during the 2nd quarter worth approximately $128,133,000. ARK Investment Management LLC boosted its position in shares of Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock worth $134,604,000 after acquiring an additional 1,855,459 shares in the last quarter. Finally, Alphabet Inc. acquired a new stake in shares of Tempus AI during the 2nd quarter worth approximately $54,289,000.

Tempus AI Company Profile

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read More

Should you invest $1,000 in Tempus AI right now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines